Eam Investors, LLC Harrow Health, Inc. Transaction History

Eam Investors, LLC

$581 Million
Q3 2024

A detailed history of Eam Investors, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Eam Investors, LLC holds 92,819 shares of HROW stock, worth $3.62 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

92,819

Holding current value

$3.62 Million

% of portfolio

0.72%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$20.85 - $46.47 $1.94 Million - $4.31 Million	92,819 New	92,819 $4.17 Million
Q2 2023 Aug 11, 2023	SELL	$17.37 - $28.08 $4.4 Million - $7.11 Million	-253,128 Reduced 81.67%	56,806 $1.08 Million
Q1 2023 Jul 12, 2023	SELL	$13.84 - $21.46 $1.07 Million - $1.66 Million	-77,259 Reduced 19.95%	309,934 $6.56 Million
Q1 2023 May 12, 2023	BUY	$13.84 - $21.46 $2.14 Million - $3.31 Million	154,285 Added 66.24%	387,193 $8.19 Million
Q4 2022 Feb 14, 2023	BUY	$10.28 - $14.78 $91,101 - $130,980	8,862 Added 3.96%	232,908 $3.44 Million
Q3 2022 Nov 14, 2022	BUY	$6.57 - $24.88 $1.47 Million - $5.57 Million	224,046 New	224,046 $2.7 Million
Q3 2021 Nov 12, 2021	SELL	$6.99 - $10.6 $994,481 - $1.51 Million	-142,272 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$6.68 - $11.07 $950,376 - $1.57 Million	142,272 New	142,272 $1.32 Million
Q3 2019 Nov 13, 2019	SELL	$4.89 - $8.0 $480,535 - $786,152	-98,269 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$4.2 - $8.7 $102,240 - $211,784	-24,343 Reduced 19.85%	98,269 $855,000
Q1 2019 May 13, 2019	BUY	$4.75 - $7.1 $582,407 - $870,545	122,612 New	122,612 $611,000

Others Institutions Holding HROW

# of Institutions

176

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.06B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.

Account

Eam Investors, LLC Harrow Health, Inc. Transaction History